Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Health Tech
Biotech
AstraZeneca pays CSPC $30M to form kidney drug discovery pact
AstraZeneca has committed up to $1.7 billion in milestones to jointly discover and develop two kidney disease drug candidates with CSPC.
Nick Paul Taylor
Jul 3, 2026 8:00am
With $15M, BI becomes latest to buy into Immunai’s AI platform
Jun 25, 2026 9:00am
Insilico lands backloaded $2.5B AI deal with SK Biopharm
Jun 22, 2026 12:30am
Altaris scoops up AI drug development outfit for $375M
Jun 16, 2026 12:13pm
Merck inks $510M biobucks data partnership with Protillion
Jun 16, 2026 10:06am
Fierce Healthcare
HHS ramps up AI use cases, with most in pre-deployment: BPC
Jun 11, 2026 2:00pm